| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $87.3M | +58.3% |
| SG&A Expense | $27.5M | +29.0% |
| Operating Income | -$114.8M | -103.6% |
| Interest Expense | $1K | -75.0% |
| Pre-tax Income | -$104.7M | -84.5% |
| Income Tax | $0 | -100.0% |
| Net Income | -$104.7M | -78.2% |
| EPS (Basic) | -$4.15 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $279.0M | +21.3% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $285.8M | +13.7% |
| Total Assets | $306.8M | +20.2% |
| Current Liabilities | $16.5M | +39.7% |
| Total Liabilities | $29.4M | +143.1% |
| Stockholders' Equity | $277.4M | +14.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.1M | -12.7% |
| Capital Expenditures | $1.2M | +21.2% |
| Investing Cash Flow | -$1.2M | -21.2% |
| Financing Cash Flow | $120.3M | +321.4% |
| Free Cash Flow | -$71.3M | -12.9% |
| -64.7% |
| EPS (Diluted) | -$4.15 | -64.7% |